AReNA sponsors Rendez-vous Québec at the launch of the BIO International Convention

June 17, 2025

One the evening of Monday June 16, AReNA had the pleasure of sponsoring Rendez-vous Québec, the must-attend networking cocktail that kicks off the BIO International Convention!

Over 420 key players from the life sciences ecosystem gathered to connect, exchange ideas, and celebrate innovation. The AReNA team thoroughly enjoyed engaging with partners from Quebec, across Canada, and around the world.

AReNA would like to thank BIOQuébec for organizing such a high-impact event!

Xavier Linker (CQDM), Panagiotis Prinos (McGill), Nadia Dubé (IRCM), Alexandre Morizot (CQDM), Véronique Dugas (CQDM) and Janet Prince (D2R)

Jesse Paterson (CQDM), Alexandre Morizot, Xavier Linker and Véronique Dugas

More information about Quebec’s RNA sector

Quebec’s RNA ecosystem at a glance

Funding for company-driven RNA innovation

Industry news

June 18, 2025

Médicament Québec Awards Two Major Grants for RNA Innovation with Financial Support from the Ministère de l’Économie, de l’Innovation et de l’Énergie (MEIE)

Learn more

June 17, 2025

MedicalExpo E-Magazine article highlights AReNA’s panelists at 2025 EFFERVESCENCE on RNA Therapies: From Pandemic Vaccines to Tomorrow’s Medicine.

Learn more

May 8, 2025

The creation of a biomanufacturing services platform to boost expertise in Quebec and accelerate the development of RNA therapies

Learn more

June 6, 2024

AReNA sponsors Rendez-vous Québec at the launch of the BIO International Convention

More information about Quebec’s RNA sector

Industry news

Médicament Québec Awards Two Major Grants for RNA Innovation with Financial Support from the Ministère de l’Économie, de l’Innovation et de l’Énergie (MEIE)

AReNA shines at BIO 2025

Pharmaceutiques Magazine spotlights Quebec, driving force for North America’s RNA Sector

DirectIndustry’s take on AReNA, Quebec’s Ambitious Plan to Become a Global RNA Therapeutics Leader

MedicalExpo E-Magazine article highlights AReNA’s panelists at 2025 EFFERVESCENCE on RNA Therapies: From Pandemic Vaccines to Tomorrow’s Medicine.

D2R et AReNA put RNA experts forward at the 92nd ACFAS Congress

AReNA’s expert panel and networking breakfast energize EFFERVESCENCE conference in Montreal

Panagiotis Prinos appointed as Director of Réseau DePTAQ

The AReNA breakfast series presents the CELLULE and the RNA valorisation and entrepreneurship team.

CASTL and the DePTAQ Network present their initiative during AReNA’s breakfast event at IRCM

Jean-Pierre Perreault is elected as Rector of Université de Sherbrooke

Two panelists represent AReNA at Leyton Connect’s 5-to-7

AReNA attended FISQ

AReNA attends CASTL’s Open Door Day

Epitopea closes their $31 million pre-Series A financing.

Congratulations to the Nobel Prize winners in Medicine!

Congratulations to the 23 recipients of the D2R funding programs

The creation of training programs to meet the needs of the RNA therapeutics industry

The creation of a biomanufacturing services platform to boost expertise in Quebec and accelerate the development of RNA therapies

A new initiative to stimulate innovation and entrepreneurship in the RNA therapy sector in Quebec

Quebec Launches AReNA to Become a Global Leader in RNA Therapies

A group of partners are launching the CELLULE to accelerate the development of RNA therapies in Quebec

The long-overlooked molecule that will define a generation of science

AReNA sponsors Rendez-vous Québec at the launch of the BIO International Convention

More information about Quebec’s RNA sector

Industry news

Médicament Québec Awards Two Major Grants for RNA Innovation with Financial Support from the Ministère de l’Économie, de l’Innovation et de l’Énergie (MEIE)

AReNA shines at BIO 2025

Pharmaceutiques Magazine spotlights Quebec, driving force for North America’s RNA Sector

DirectIndustry’s take on AReNA, Quebec’s Ambitious Plan to Become a Global RNA Therapeutics Leader

MedicalExpo E-Magazine article highlights AReNA’s panelists at 2025 EFFERVESCENCE on RNA Therapies: From Pandemic Vaccines to Tomorrow’s Medicine.

D2R et AReNA put RNA experts forward at the 92nd ACFAS Congress

AReNA’s expert panel and networking breakfast energize EFFERVESCENCE conference in Montreal

Panagiotis Prinos appointed as Director of Réseau DePTAQ

The AReNA breakfast series presents the CELLULE and the RNA valorisation and entrepreneurship team.

CASTL and the DePTAQ Network present their initiative during AReNA’s breakfast event at IRCM

Jean-Pierre Perreault is elected as Rector of Université de Sherbrooke

Two panelists represent AReNA at Leyton Connect’s 5-to-7

AReNA attended FISQ

AReNA attends CASTL’s Open Door Day

Epitopea closes their $31 million pre-Series A financing.

Congratulations to the Nobel Prize winners in Medicine!

Congratulations to the 23 recipients of the D2R funding programs

The creation of training programs to meet the needs of the RNA therapeutics industry

The creation of a biomanufacturing services platform to boost expertise in Quebec and accelerate the development of RNA therapies

A new initiative to stimulate innovation and entrepreneurship in the RNA therapy sector in Quebec

Quebec Launches AReNA to Become a Global Leader in RNA Therapies

A group of partners are launching the CELLULE to accelerate the development of RNA therapies in Quebec

The long-overlooked molecule that will define a generation of science

Stay up to date with the latest news on RNA therapies